The aim of the present study is to investigate the genes significantly related to MLL-r ALL and elucidate the mechanisms of how MLL fusions and their partner genes lead to leukemogenesis, which may provide novel therapeutic targets for ALL with MLL-r. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.